Latest News

  • INNOVATION

    25 Feb 2026

    Can AI Rethink How New Drugs Are Found?

  • PARTNERSHIPS

    24 Feb 2026

    Lilly Deepens AI Push in Obesity Drug Race

  • INVESTMENT

    23 Feb 2026

    Another Shot in the Obesity Gold Rush

  • MARKET TRENDS

    19 Feb 2026

    Precision Medicine Rises as Biomarkers Drive Change

Pfizer Steps Up Obesity Push With Metsera Deal

Pfizer corporate logo displayed outside office building

PARTNERSHIPS

17 Feb 2026

US drugmaker agrees multibillion-dollar acquisition to bolster metabolic pipeline and challenge leaders in weight-loss therapies

Researchers reviewing biopsy data on tablet beside lab glassware and test tubes

INNOVATION

12 Dec 2025

FDA Qualifies AI Tool to Support MASH Clinical Trials

FDA qualification of an AI pathology tool could streamline MASH trials by improving consistency, hinting at broader acceptance of AI in dr...

Assorted tablets in blister packs showcasing breakthroughs in metabolic therapies.

MARKET TRENDS

11 Dec 2025

Metabolic Breakthroughs Fuel Race for Next Gen Therapies

Lilly’s data and Zealand’s Roche pact accelerate a fast-shifting field of metabolic care

Digital drug discovery interface displayed on illuminated screens at biotech research center

TECHNOLOGY

10 Dec 2025

AI Heats Up the Search for New Metabolic Treatments

AI efforts from Insilico, Nabla Bio, and Takeda speed early metabolic drug design and push firms toward faster data focused R and D

Aerial view of Novo Nordisk headquarters with circular glass roof

PARTNERSHIPS

9 Dec 2025

Metabolic Deals Speed a New US Race to Transform Liver Care

Novo Nordisk’s move for Akero boosts momentum in metabolic care; industry players should prepare for faster shifts in liver-disease treatm...

Aardvark Therapeutics logo featuring stylized A and molecular design.

INSIGHTS

8 Dec 2025

The Oral Bet Challenging Today’s GLP 1 Era

Aardvark and Rivus advance early stage metabolic therapies as interest grows beyond GLP 1 drugs and potential new options emerge

Orforglipron pill bottle beside scale and measuring tape for metabolic treatment research

RESEARCH

5 Dec 2025

Oral Obesity Drug Fuels Competition in Metabolic Care

Lilly’s oral orforglipron heats up the race to reshape obesity and diabetes treatment

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.